Launch week offerEnds in00h00m00s
annual Promonthly Pro
Ayman Ibrahim
Lecturer
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (6)
Year:
2026
Year:
2025
Year:
2025
Year:
2024
Atrial fibrillation (AF) is the most common chronic arrhythmia presenting a heavy disease burden. We report a new approach for generating cardiomyocytes (CMs) resembling atrial cells from human-induced pluripotent stem cells (hiPSCs) using a combination of Gremlin 2 and retinoic acid treatment. More than 40% of myocytes showed rod-shaped morphology, expression of CM proteins (including ryanodine receptor 2, α -actinin-2 and F-actin) and striated appearance, all of which were broadly similar to the characteristics of adult atrial myocytes (AMs). Isolated myocytes were electrically quiescent until stimulated to fire action potentials with an AM profile and an amplitude of approximately 100 mV, arising from a resting potential of approximately −70 mV. Single-cell RNA sequence analysis showed a high level of expression of several atrial-specific transcripts including NPPA , MYL7 , HOXA3 , SLN , KCNJ4 , KCNJ5 and KCNA5 . Amplitudes of calcium transients recorded from spontaneously beating cultures were increased by the stimulation of α -adrenoceptors (activated by phenylephrine and blocked by prazosin) or β -adrenoceptors (activated by isoproterenol and blocked by CGP20712A). Our new approach provides human AMs with mature characteristics from hiPSCs which will facilitate drug discovery by enabling the study of human atrial cell signalling pathways and AF. This article is part of the theme issue ‘The heartbeat: its molecular basis and physiological mechanisms’.
Year:
2023
Year:
2023
Collaborators (6)
Joan Bausells
Research Professor
-
Davor Pavlovic
Professor
University of Birmingham
Yasmine Aguib
Hon. Senior Research Fellow
Imperial College London
Derek A. Terrar
University of Oxford
Christopher O'Shea
Assistant Professor of Molecular Cardiology
University of Warwick
Olaf Bergmann
Research Group Leader
Karolinska Institutet
Make your next move.
Prepare your application
Review drafts before you send them.